Two new eudesmane-type sesquiterpenoid lactones, named chlorelactone A (1) and chlorelactone B (2), and one new labdane-type diterpenoid, named elatiorlabdane (3), along with seven known sesquiterpenoids and one known disesquiterpenoid were isolated from the whole plants of Chloranthus elatior. Their structures and relative configurations were established on the basis of extensive spectroscopic analysis.
Introduction
The genus Chloranthus (Chloranthaceae) has about 17 species in the world, and 13 species and 5 varieties of this genus are distributed in China.
1,2 Some plants of this genus have been used in Chinese folk medicine for the treatment of bone fractures. 3 Previous work on this genus indicated that sesquiterpenoids and disesquiterpenoids were their major secondary metabolites. [4] [5] [6] [7] [8] [9] [10] [11] Disesquiterpenoids were reported to exhibit inhibition of cell adhesion molecule expression, antifungal activity, anti-HIV-1 activity, tumor growth inhibitory activity, potent and selective inhibition on the delayed rectifier (I k ）K + current. 10, 11 The tyrosinase inhibitory activity and cytotoxicity of sesquiterpenoids also have been reported. 12, 13 Chloranthus elatior is a perennial plant and grows in the Southwest of China. Recent phytochemical investigation on this species reported 18 compounds including nine sesquiterpenoids and four diterpenoids. 8 In the course of our group searching for new sesquiterpenoids from Chloranthus species, two new eudesmane-type sesquiterpenoid lactones, named chlorelactone A (1) and chlorelactone B (2), and one new labdane-type diterpenoid, named elatiorlabdane (3), along with seven known sesquiterpenoids, spathulenol (4), 14 4α-hydroxy-5α,8β(H)-eudesm-7(11)-en-8,12-olide (5), 6 4α-hydroxy-5α,8α(H)-eudesm-7(11)-en-8,12-olide (6), 6 neolitacumone B (7), 15 chlorantholide D (8), 8 4α,8β-dihydroxy-5α(H)-eudesm-7(11)-en-8,12-olide (9), 6 chloranthalic acid (10), 16 and one disesquiterpenoid, chloramultilide C (11) 17 were isolated from the whole plants of C. elatior. Herein, we report the isolation and structural elucidation of these compounds.
Results and Discussion
Chlorelactone A (1) was obtained as a white amorphous powder, and its molecular formula was established as C 15 4 (s) . The above NMR spectroscopic data suggested that 1 was an eudesmane-type sesquiterpenoid lactone, which has been widely discovered from this genus. [4] [5] [6] [7] [8] Comparison of NMR data of 1 with those of neolitacumone B (7) 15 indicated that 1 differed from 7 by the presence of a methyl (δ H 0.93, d, J = 6.0 Hz and δ C 19.8) and a methine (δ H 1.48, m and δ C 31.6) instead of one terminal double bond in 7, which was reasonable to assume that 1 is the 4,15-dihydrogenation derivative of 7. In the HMBC spectrum (Figure 1 ), the correlations of Me-15 (δ H 0.93) with C-3 (δ C 33.8), C-4 (δ C 31.6), and C-5 (δ C 50.6) were observed, which confirmed the above assumption. In addition, the HMBC correlations from δ H 1.00 (Me-14) to δ C 78.2 (C-1), δ C 50.6 (C-5), δ C 44.5 (C-9), and δ C 40.3 (C-10) hinted that one hydroxyl group was attached at C-1. The relative configuration of 1 was established by a ROESY experiment (Figure 2 ), in which the correlations from Me-14 to H-4 and H-8 indicated that they were on the same side of the rings and were randomly assigned being β-oriented. Consequently, the ROESY correlations of Me-15/H-5 and H-5/H-1 suggested that H-1 and H-5 had α-orientation. Thus, compound 1 was identified as 1β-hydroxy-4β,5α,8β(H)-eudesm-7(11)-en-12,8α-olide.
Chlorelactone B (2) (Table 2) showed three methyl proton signals at δ H 0.80, 1.14, and 1.72, three olefinic proton resonances at δ H 4.32 (1H, s, H-17), 4.68 (1H, s, H-17), and 6.79 (t, J = 5.1 Hz, H-14), and two oxymethylene proton signals at δ H 4.34 (d, J = 5.1 Hz, H-15). In its 13 C NMR spectrum, 20 resonances (Table 2) were classified by DEPT experiments into three methyls at δ C 11.7, 15.4, and 17.1, seven methylenes (one oxygenated), two methines, two quaternary carbons, four olefinic carbons at δ C 150.2 (s), 142.1 (d), 137.9 (s), and 107.4 (t), a carboxyl at δ C 182.4, and a keto carbonyl at δ C 203.1. The above NMR spectroscopic data and the degrees of unsaturation suggested that compound 3 should be a bicyclic-labdane diterpenoid. 6, 18, 19 Comprehensive analysis of 2D-NMR spectrum (HMQC, 1 H-1 H COSY, and HMBC spectrum) of 3 allowed to identify that compound 3 had the same planar structure as henrilabdane C [15-hydroxy-12-oxolabda-8(17),13E-dien-19-oic acid]. 18, 19 Comparison of NMR data of 3 with those of henrilabdane C exhibited the major difference was the configuration at C-4 as judged from the obvious changes of chemical shifts of the carbons around C-4. The ROESY cross-peak (Figure 2 ) from δ H 1.14 (Me-19) 
Experimental Section
General Experimental Procedures. Optical rotations were measured on a JASCO P-1020 digital polarimeter. UV spectra were measured using a Shimadzu UV-2401 PC spectraphotometer. IR spectra were obtained on a Bruker Tensor-27 infrared spectrophotometer with KBr pellets. ESIMS spectra were recorded on a Bruker HTC/Esquire spectrometer, HRESIMS spectrum was recorded on an API Qstar Pulsar instrument. HREIMS spectra were recorded on a Waters AutoSpec Premier P776 instrument. 1D and 2D NMR experiments were performed on Bruker AM-400 and Avance III 600 instruments with TMS as the internal standard. Chemical shifts (δ) were expressed in ppm with reference to the solvent signals. Column Chromatography (CC) was performed on silica gel Fraction IV (62 g) was subjected to an MCI gel column chromatography (MeOH-H 2 O, 1:1→1:0, v/v) to get subfractions IVa and IVb. Fr. IVa was separated by silica gel CC (petroleum ether-EtOAc, 10:1) to get 5 (7 mg), while Fr. IVb was separated by silica gel CC (petroleum ether-EtOAc, 10:1) and then semi-preparative HPLC to obtain 1 (2 mg), 6 (3 mg), 7 (10 mg), and 8 (11 mg). Fraction V (31g) was dealt with a MCI gel and a silica gel CC (CHCl 3 -MeOH, 200:1) to afford 11 (15 mg) . Fraction VI (45 g) was subjected to a MCI gel CC to get three subfractions (VIa, VIb, and VIc), which were extensively purified on a silica gel column (CHCl 3 -MeOH, 100:1) and Sephadex LH-20 (MeOH) to afford 9 (15 mg) and 10 (8 mg) from Fr. VIa, afford 3 (11 mg) from Fr. VIb, and afford 2 (9 mg) from Fr. VIc. 
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